Page last updated: 2024-08-25

dracorhodin and Hyperglycemia, Postprandial

dracorhodin has been researched along with Hyperglycemia, Postprandial in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Y; Hou, M; Huang, Y; Huo, M; Li, Y; Liang, C; Liu, L; Mei, P; Song, Z; Sun, L; Sun, Y; Wang, G; Wang, S; Wu, Y; Yang, S; Yi, J; Yu, C; Zheng, L; Zhu, H	1

Other Studies

1 other study(ies) available for dracorhodin and Hyperglycemia, Postprandial

Article	Year
Dracorhodin perchlorate protects pancreatic β-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo. The FEBS journal, 2019, Volume: 286, Issue:18 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzopyrans; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; HEK293 Cells; Homeodomain Proteins; Humans; Hyperglycemia; Insulin; Insulin-Secreting Cells; MAP Kinase Signaling System; Mice; Palmitates; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Trans-Activators	2019

Article

Year

Dracorhodin perchlorate protects pancreatic β-cells against glucotoxicity- or lipotoxicity-induced dysfunction and apoptosis in vitro and in vivo.

The FEBS journal, 2019, Volume: 286, Issue:18

Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzopyrans; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Glucose; HEK293 Cells; Homeodomain Proteins; Humans; Hyperglycemia; Insulin; Insulin-Secreting Cells; MAP Kinase Signaling System; Mice; Palmitates; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Trans-Activators

2019